EMA-FDA parallel scientific advice program has ‘limited’ uptake

14 March 2023 - A review of the last five years of the parallel scientific advice program between the FDA ...

Read more →

EMA pilots scientific advice for certain high risk medical devices

27 February 2023 - The EMA has launched a pilot to give scientific advice on the intended clinical development strategy ...

Read more →

New online platform for scientific advice

7 October 2020 - From 19 October 2020, developers of human or veterinary medicines should use EMA’s IRIS Regulatory & ...

Read more →

Academia developing medicines for rare diseases to receive free EMA scientific advice

23 June 2020 - To further encourage the development of treatments for rare diseases, EMA will waive all fees for ...

Read more →

COVID-19: developers of medicines or vaccines to benefit from free scientific advice

13 March 2020 - EMA provides full fee waivers for scientific advice applications from developers of potential therapeutics (to treat ...

Read more →

EMA Management Board: highlights of October 2015 meeting

6 October 2015 - The Management Board heard an update on the European Medicines Agency’s (EMA) activities in the first half ...

Read more →